Xilio Therapeutics, Inc. (XLO)
Nasdaq: XLO · CIK 0001840233 · United States
Every official Xilio Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open XLO filings
Xilio Therapeutics, Inc. documents
- Xilio Therapeutics, Inc. 10-K 2026XLO 10-K 2026: annual report for fiscal 2026
- Xilio Therapeutics, Inc. 10-K 2025XLO 10-K 2025: annual report for fiscal 2025
- Xilio Therapeutics, Inc. 10-K 2024XLO 10-K 2024: annual report for fiscal 2024
- Xilio Therapeutics, Inc. 10-K 2023XLO 10-K 2023: annual report for fiscal 2023
- Xilio Therapeutics, Inc. 10-K 2022XLO 10-K 2022: annual report for fiscal 2022
- Xilio Therapeutics, Inc. 10-Q 2026XLO 10-Q 2026: quarterly report for fiscal 2026
- Xilio Therapeutics, Inc. 10-Q 2025XLO 10-Q 2025: quarterly report for fiscal 2025
- Xilio Therapeutics, Inc. 10-Q 2024XLO 10-Q 2024: quarterly report for fiscal 2024
- Xilio Therapeutics, Inc. 10-Q 2023XLO 10-Q 2023: quarterly report for fiscal 2023
- Xilio Therapeutics, Inc. 10-Q 2022XLO 10-Q 2022: quarterly report for fiscal 2022
- Xilio Therapeutics, Inc. 8-K 2026XLO 8-K 2026: current report for fiscal 2026
- Xilio Therapeutics, Inc. 8-K 2025XLO 8-K 2025: current report for fiscal 2025
- Xilio Therapeutics, Inc. 8-K 2024XLO 8-K 2024: current report for fiscal 2024
- Xilio Therapeutics, Inc. 8-K 2023XLO 8-K 2023: current report for fiscal 2023
- Xilio Therapeutics, Inc. 8-K 2022XLO 8-K 2022: current report for fiscal 2022
- Xilio Therapeutics, Inc. DEF 14A 2026XLO DEF 14A 2026: proxy statement for fiscal 2026
- Xilio Therapeutics, Inc. DEF 14A 2025XLO DEF 14A 2025: proxy statement for fiscal 2025
- Xilio Therapeutics, Inc. DEF 14A 2024XLO DEF 14A 2024: proxy statement for fiscal 2024
- Xilio Therapeutics, Inc. DEF 14A 2023XLO DEF 14A 2023: proxy statement for fiscal 2023
- Xilio Therapeutics, Inc. DEF 14A 2022XLO DEF 14A 2022: proxy statement for fiscal 2022
- Xilio Therapeutics, Inc. Form 4 2026XLO Form 4 2026: insider trading filing for fiscal 2026
- Xilio Therapeutics, Inc. Form 4 2025XLO Form 4 2025: insider trading filing for fiscal 2025
- Xilio Therapeutics, Inc. Form 4 2024XLO Form 4 2024: insider trading filing for fiscal 2024
- Xilio Therapeutics, Inc. Form 4 2023XLO Form 4 2023: insider trading filing for fiscal 2023
- Xilio Therapeutics, Inc. Form 4 2022XLO Form 4 2022: insider trading filing for fiscal 2022
- Xilio Therapeutics, Inc. S-1 2026XLO S-1 2026: registration statement for fiscal 2026
- Xilio Therapeutics, Inc. S-1 2025XLO S-1 2025: registration statement for fiscal 2025
- Xilio Therapeutics, Inc. S-1 2024XLO S-1 2024: registration statement for fiscal 2024
- Xilio Therapeutics, Inc. S-1 2023XLO S-1 2023: registration statement for fiscal 2023
- Xilio Therapeutics, Inc. S-1 2022XLO S-1 2022: registration statement for fiscal 2022
- Xilio Therapeutics, Inc. 13F 2026XLO 13F 2026: institutional holdings for fiscal 2026
- Xilio Therapeutics, Inc. 13F 2025XLO 13F 2025: institutional holdings for fiscal 2025
- Xilio Therapeutics, Inc. 13F 2024XLO 13F 2024: institutional holdings for fiscal 2024
- Xilio Therapeutics, Inc. 13F 2023XLO 13F 2023: institutional holdings for fiscal 2023
- Xilio Therapeutics, Inc. 13F 2022XLO 13F 2022: institutional holdings for fiscal 2022
More companies